Clinical trial IJB-LBC-NEOCHECKRAY-2018
Neo-adjuvant chemotherapy combined with SBRT to the primary tumor +/- durvalumab +/- oleclumab in luminal B breast cancer: a phase ll randomized trial
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Oui |
Sponsor | Institut Jules Bordet |
EudraCT Identifier | 2018-004165-13 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03875573 |
Inclusion criteria | No contraindication for immunotherapy |
Last update |